Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01744977 · ClinicalTrials.gov registry record · NA
Cholesterol Medication Packaging Study
A NA study, sponsored by Durham VA Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 240
- Enrollment target
NCT01744977: Completed NA study, sponsored by Durham VA Medical Center.
NCT01744977 is a NA study that has completed, run by Durham VA Medical Center. The registered enrollment target is 240 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01744977, a NA study, has completed, sponsored by Durham VA Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 240 participants
- Enrollment target
Study Summary
The purpose of the overall study is to improve medication use rates among veterans by looking at the risk factors of low-density lipoprotein cholesterol (LDL). It will involve patients who have high LDL-C level (\<130mg/dl) and /or may have difficulty taking their medications based on how often they refilled their medications in the last 12 months. The investigators will test an innovative adherence packaging relative to usual care. The primary hypothesis is that veterans who receive the intervention will have greater improvement in their medication adherence as measured by pill refill at 6 and 12 months of follow up as compared to the control group.
Primary Outcome
Pill refill obtained at 12 months to review change in cholesterol medication adherence over the 12 month period between groups
Interventions
- BEHAVIORAL packaging
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 240 participants |
| Start Date | 2012-12 |
| Est. Completion | 2015-08 |
| Phase | NA |
What the finished NCT01744977 record still lists
NCT01744977 is an interventional study that assigns participants to a tested intervention. The registered 240 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 1 intervention - of which packaging is the first listed.
NCT01744977 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01744977 about?
NCT01744977 is a clinical study titled "Cholesterol Medication Packaging Study". The purpose of the overall study is to improve medication use rates among veterans by looking at the risk factors of low-density lipoprotein cholesterol (LDL). It will involve patients who have high LDL-C level (\<130mg/dl) and /or may have difficulty taking their medications based on how often they...
What is the current status of trial NCT01744977?
This trial is currently completed. It is a NA study. The enrollment target is 240 participants. The study started on 2012-12. Estimated completion is 2015-08.
What interventions are being tested in trial NCT01744977?
The interventions under investigation include: packaging (BEHAVIORAL).
Who is sponsoring clinical trial NCT01744977?
This trial is sponsored by Durham VA Medical Center, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01744977's enrollment target sits among peer trials
240 440th of 2000 higher than 1,542 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02855554 · 240 participants · NA
Quantitative Cardiac Parametric Mapping
- NCT03230565 · 240 participants · Phase 4
Continuous Infusions vs Scheduled Bolus Infusions
- NCT03399929 · 240 participants
Traumatic Brain Injury and Stroke Long Term Outcome
- NCT03583710 · 240 participants · Phase 3
Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia